Analytical Data
-
基因名
ARL4A
- Application
-
别名
ADP ribosylation factor like 4; ADP ribosylation factor like 4A; ADP ribosylation factor like GTPase 4A; ADP-ribosylation factor-like protein 4A; ARL 4; ARL4; Arl4a; ARL4A_HUMAN
-
种属
Human
-
表达系统
E. coli
-
标签
N- His
-
纯度
Greater than 90% as determined by SDS-PAGE.
-
蛋白编号
P40617
-
表达区间
2-200aa
-
分子量
26.5 kDa
-
内毒素
< 1.0 EU per μg protein as determined by the LAL method.
-
性状
Freeze-dried powder
-
缓冲液
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
复溶方法
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- 个性化定制
-
稳定性测试
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
保存条件 & 期限
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
运输条件
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
ARL4A (ADP-ribosylation factor-like 4A) is a member of the ARF family of GTPases, which play crucial roles in various cellular processes, including vesicle trafficking, cytoskeletal organization, and signal transduction. Originally identified in studies focused on the regulation of membrane dynamics, ARL4A has garnered attention for its potential involvement in cancer biology and other diseases. Research indicates that ARL4A may influence cell proliferation, migration, and invasion by modulating actin cytoskeleton dynamics, particularly through its interaction with other proteins and cellular pathways. Additionally, evidence suggests that ARL4A could affect the activity of downstream effectors related to cell signaling. As the understanding of ARL4A's mechanisms evolves, its potential as a therapeutic target is being explored, particularly in cancer research where aberrant GTPase signaling is frequently implicated. Studies on ARL4A recombinantly expressed proteins aim to elucidate its structure-function relationships and interaction networks, providing insights into the modulation of cellular processes and the potential development of ARL4A-targeted therapies.
